ENTITY
Merck & Co

Merck & Co (MRK US)

228
Analysis
Health CareUnited States
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.
more
bullishMerck & Co
27 Jun 2025 04:00

Merck & Co. Unleashes a Bold Oncology Offensive—Will KEYTRUDA’s Expansion Rewrite Cancer Care?

Merck & Co., Inc. reported its first-quarter 2025 financial results with a mix of strengths and challenges. Overall, the company maintained...

Logo
208 Views
Share
bullishMerck & Co
26 Mar 2025 13:00

Merck’s $25 Billion Lifeline Is About to Expire — Here’s the Bold Plan to Replace It!

Merck & Co.'s fourth-quarter 2024 financial performance reflects a complex landscape of strength in some areas alongside challenges in...

Logo
179 Views
Share
bullishMerck & Co
22 Nov 2024 15:00

Merck & Co. Inc.: Expanding Oncology Portfolio through KEYTRUDA Developments & Partnership Collaborations To Shape the Future! - Major Drivers

Merck & Co. has demonstrated robust operational performance and strategic advances in its third quarter earnings, navigating through both...

Logo
440 Views
Share
bullishMerck & Co
31 Oct 2024 16:17Podcast

Merck & Co: Blockbuster Drugs - [Business Breakdowns, EP.189]

Business Breakdowns explores Merck, a leading pharmaceutical company known for innovation in oncology and future drug pipeline, navigating...

Logo
945 Views
Share
bullish3SBio Inc
01 Jul 2025 08:30

3SBio Inc (1530 HK): Licensing Deal a Market Hit; Will It Continue?

​3SBio signed $6B outlicensing deal with Pfizer for SSGJ-707, resulting in spectacular rally in 3SBio shares. Global trial initiation of SSGJ-707...

Logo
174 Views
Share
x